10-Year Follow-Up of a Prospective Randomized Trial Comparing Bare-Metal Stenting With Internal Mammary Artery Grafting for Proximal, Isolated De Novo Left Anterior Coronary Artery StenosisThe SIMA (Stenting versus Internal Mammary Artery grafting) Trial
Jean-Jacques Goy, MD, FESC*,*,
Urs Kaufmann, MD, FESC ,
Michel Hurni, MD*,
Stéphane Cook, MD ,
Francesco Versaci, MD ,
Patrick Ruchat, MD*,
Osmund Bertel, MD, FESC, FACC ,
Michael Pieper, MD||,
Bernhard Meier, MD, FESC, FACC ,
Luigi Chiarello, MD ,
Eric Eeckhout, MD, FESC, PhD* for the SIMA Investigators
* Service de Cardiologie, University Hospital, Lausanne, Switzerland
Kardiologie Abteilung, University Hospital, Bern, Switzerland
Policlinico Tor Vergata, Tor Vergata University, Rome, Italy
HerzGefässZentrum, Zürich, Switzerland
|| Herzzentrum Bodensee, Kreuzlingen, Switzerland

View larger version (10K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Event-Free Survival Curves
Event-free survival curves for death and myocardial infarction for percutaneous coronary intervention (PCI) (red) and coronary artery bypass grafting (CABG) (black) (p = 0.9) and event-free survival curves for death, myocardial infarction, and additional revascularization for PCI (green) and CABG (yellow) (p < 0.0004).
|
|
|